Trials / Active Not Recruiting
Active Not RecruitingNCT07512791
Effect of Bagua Auriculotherapy on Pain in Patients Undergoing Hysteroscopy
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 132 (estimated)
- Sponsor
- The Fourth Affiliated Hospital of Zhejiang University School of Medicine · Academic / Other
- Sex
- Female
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
To investigate the application of Bagua ear therapy as an adjunctive intervention for perioperative pain management in patients undergoing hysteroscopic surgery, to analyze its effects on intraoperative and postoperative pain, and to compare the differences in pain outcomes between patients undergoing hysteroscopy under local anesthesia and those without anesthesia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Paracervical block anesthesia | The control group received paracervical block anesthesia with 0.1 g lidocaine, without combined Bagua auriculotherapy. |
| PROCEDURE | Bagua Auriculotherapy | For the intervention, Vaccaria seeds were attached to selected auricular points using adhesive tape. The auricular skin was disinfected with 75% alcohol wipes. According to Bagua theory, the seeds were placed at the Kan, Li, Gen, and Qian positions, localized based on the Group Standard of Guangdong Provincial Association of Traditional Chinese Medicine (T/GDACM0143-2025): "Bagua Auriculotherapy Localization and Compatibility". Manual pressure was applied using the thumb and index finger pads on each point. The pressing procedure commenced 15 minutes before surgery, with each point pressed 30 times in the sequence of Kan, Li, Gen, and Qian, repeated for three cycles, until sensations of warmth, pain, numbness, or distension were achieved. Immediately after surgical incision, each point was pressed 30 times following the same sequence for three cycles, and immediately after surgery completion, each point was again pressed 30 times for three cycles. |
Timeline
- Start date
- 2026-03-01
- Primary completion
- 2026-08-31
- Completion
- 2026-08-31
- First posted
- 2026-04-06
- Last updated
- 2026-04-06
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07512791. Inclusion in this directory is not an endorsement.